“Melphalan/HDS delivered meaningful improvements ... In Europe, the device-only configuration of the HDS is regulated as a Class III medical device and is marketed under the trade name CHEMOSAT ...

Sanofi's Sarclisa has been an also-ran in the anti-CD38 antibody class behind Johnson & Johnson ... or bortezomib, melphalan, and prednisone for the transplant-ineligible group.

Delcath Systems, Inc. , an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced the publication of a comparative analysis from the ...

This was followed in August 2023 by Delcath Systems’ Hepzato (melphalan for injection/hepatic ... 1 checkpoint inhibitor pembrolizumab with a Class 1 histone deactylase (HDAC) inhibitor entinostat.

MHC class I chain-related protein A/B; mRNA, messenger ribonucleic acid; NCAM, neural cell adhesion molecule; NK, natural killer cell; NKG2A, natural killer cell lectin-like receptor subfamily A; ...

Oncologists are increasingly favoring CAR T-cell therapy’s early-line use in relapsed/refractory multiple myeloma despite challenges like cost and access.